• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE VIABAHN ENDOPROSTHESIS WITH PROPATEN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE VIABAHN ENDOPROSTHESIS WITH PROPATEN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number PAHR081002E
Device Problems Off-Label Use (1494); Insufficient Information (3190)
Patient Problem Obstruction/Occlusion (2422)
Event Date 04/06/2021
Event Type  Injury  
Manufacturer Narrative
Patient information: the patient information was not provided.As the device remains implanted and the accessories were discarded on site, an evaluation of the device cannot be performed.(b)(4).A review of the manufacturing records indicated the lot met all pre-release manufacturing specifications.Ifu statement: in the ifu for the gore® viabahn® endoprosthesis with propaten bioactive surface the following was stated under the chapter warnings: the gore® viabahn® endoprosthesis with propaten bioactive surface is not indicated for use in the central circulatory system; such as, pulmonary arteries, aorta, coronary arteries, coronary bypass grafts, coronary sinus, carotid arteries, vertebral arteries, brachiocephalic (innominate) arteries, vena cavae or pulmonary veins.This event is considered as "off label-use".Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
It was reported to gore that patient underwent endovascular treatment for a pseudo carotid aneurysm with a gore® viabahn® endoprosthesis with propaten bioactive surface (viabahn-device).It was stated that the procedure went well and during the final run the graft was found patent.It was reported that the following morning the patient had a stroke score of 20.He was transferred to another hospital to interventional radiology department for thrombectomy.It was stated that the stroke score was reduced to 6.
 
Event Description
Updated description: it was reported to gore that patient underwent endovascular treatment for a pseudo carotid aneurysm with a gore® viabahn® endoprosthesis with propaten bioactive surface (viabahn-device).It was stated that the procedure went well and during the final run the graft was found patent.It was reported that the following morning the patient had a stroke score of 20.He was transferred to another hospital to interventional radiology department for thrombectomy.It was stated that the stroke score was reduced to 6.The distributor stated that he was advised that the viabahn-device occluded after the procedure.The patient was transferred to another hospital for a thrombectomy.This is all the information he was provided.
 
Manufacturer Narrative
H6 evaluation codes investigation findings 213 refers to phr-review.Product investigation conclusion: the specific cause of this complaint could not be determined.Gore did not receive the explanted device, and information regarding the device form was not available.A product history review was conducted for the viabahn-device in this complaint, and the review of the manufacturing records, including the manufacturing, heparin coatings, and sterilization processes, indicated the lot met pre-release manufacturing specifications.The investigation confirms the complaint of occlusion, but the cause cannot be confirmed.B5 describe event or problem was updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS WITH PROPATEN BIOACTIVE SURFACE
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key11840462
MDR Text Key263365201
Report Number2017233-2021-02014
Device Sequence Number1
Product Code NIP
Combination Product (y/n)Y
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,health pr
Type of Report Initial,Followup
Report Date 08/04/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/18/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/09/2023
Device Catalogue NumberPAHR081002E
Was Device Available for Evaluation? No
Date Manufacturer Received08/04/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-